{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ababneh NA"],"funding":["European Union Innovative Medicines Initiative","University of Jordan","Medical Research Council","National Institute for Health Research (NIHR)","Motor Neurone Disease Association","Oxford Martin School","Wellcome Trust","Academy of Medical Sciences","Parkinson's UK"],"pagination":["2200-2217"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7399532"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["29(13)"],"pubmed_abstract":["The G4C2 hexanucleotide repeat expansion (HRE) in C9orf72 is the commonest cause of familial amyotrophic lateral sclerosis (ALS). A number of different methods have been used to generate isogenic control lines using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 and non-homologous end-joining by deleting the repeat region, with the risk of creating indels and genomic instability. In this study, we demonstrate complete correction of an induced pluripotent stem cell (iPSC) line derived from a C9orf72-HRE positive ALS/frontotemporal dementia patient using CRISPR/Cas9 genome editing and homology-directed repair (HDR), resulting in replacement of the excised region with a donor template carrying the wild-type repeat size to maintain the genetic architecture of the locus"],"journal":["Human molecular genetics"],"pubmed_title":["Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair."],"pmcid":["PMC7399532"],"funding_grant_id":["832-791","MR/M024962/1","CL-2015-26-001","MC_PC_15065","SGL014\\1004","TALBOT/OCT16/889-792","WTISSF121302","MR/P007023/1","115439","MC_EX_MR/N50192X/1","TURNER/OCT18/989-797","LC0910-004","MR/L023784/1","TALBOT-MUTIHAC/APR15/832-791","MR/L002167/1","J-0901","090532/Z/09/Z","SCABER/JULY13/945-795","TALBOT/JULY13/820-791","J-1403","945-795"],"pubmed_authors":["Talbot K","Ababneh NA","Turner MR","Flynn R","Douglas A","Barbagallo P","Dafinca R","Cowley SA","Scaber J","Sims D","Candalija A"],"additional_accession":[]},"is_claimable":false,"name":"Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.","description":"The G4C2 hexanucleotide repeat expansion (HRE) in C9orf72 is the commonest cause of familial amyotrophic lateral sclerosis (ALS). A number of different methods have been used to generate isogenic control lines using clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 and non-homologous end-joining by deleting the repeat region, with the risk of creating indels and genomic instability. In this study, we demonstrate complete correction of an induced pluripotent stem cell (iPSC) line derived from a C9orf72-HRE positive ALS/frontotemporal dementia patient using CRISPR/Cas9 genome editing and homology-directed repair (HDR), resulting in replacement of the excised region with a donor template carrying the wild-type repeat size to maintain the genetic architecture of the locus","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Aug","modification":"2026-04-14T19:18:42.353Z","creation":"2022-02-11T02:33:26.257Z"},"accession":"S-EPMC7399532","cross_references":{"pubmed":["32504093"],"doi":["10.1093/hmg/ddaa106"]}}